Lexington-based Imprivata is teaming up with Microsoft to launch healthcare’s first end-to-end Identity and Access Management (IAM) Cloud Platform. The Platform, anchored by Imprivata’s leading solution portfolio and commitment to building trusted digital identities, and the world-class scale and security of Microsoft’s cloud identity platform, Azure Active Directory, will address the unique challenges that healthcare customers face along the digital transformation journey.
Phase 1 Collaboration: Imprivata Launches Healthcare Seamless SSO
This is just phase one of a long-term collaboration between the two companies. Imprivata today launched Healthcare Seamless SSO, enterprise single sign-on into on all shared clinical workstations and mobile devices. Healthcare Seamless SSO extends the Tap-In and Tap-Out capabilities of Imprivata OneSign®, allowing badge tap access into Office 365 and any application connected to Microsoft Azure Active Directory, including the extensive catalog of cloud-based applications in Microsoft Azure Marketplace.
Eliminating the Need for Clinicians to Repeatedly Type Usernames & Passwords
The platform eliminates the need for clinicians and other users to repeatedly type usernames and passwords to access various programs/apps via shared worked stations, saving care providers 45 minutes per shift while driving EMR adoption. In addition, the platform is also built to enhance workflows for electronic prescriptions for controlled substances (EPCS), which is key ahead of the new federal law slated to take effect on January 1st, 2020.
“We’re delighted to announce this strategic collaboration with Microsoft and to introduce the Imprivata IAM Cloud Platform, which first brings the simplicity of Tap-In and Tap-Out to the cloud, and seamlessly supports access to Microsoft cloud applications like Microsoft Office 365 and more for our 1,945 healthcare customers” said Gus Malezis, President and CEO at Imprivata. “Furthermore, the Platform leverages the existing Imprivata investments of our joint customers, enhancing the ROI of their current and future technology investments.”
